Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

Immix Biopharma (IMMX)

Latest price

USD5.23

−0.05 (−0.95)
As at 01/01/2026
Market capitalisation
USD176m
View equity

IRLAB Therapeutics (IRLAB-A)

Latest price

SEK1.97

0.05 (2.60)
As at 01/01/2026
Market capitalisation
SEK168m
View equity

KALA BIO (KALA)

Latest price

USD0.56

−0.01 (−1.77)
As at 01/01/2026
Market capitalisation
USD6m

LTR Pharma (LTP)

Latest price

AUD0.72

0.07 (10.77)
As at 01/01/2026
Market capitalisation
AUD131m
View equity

Medigene (MDG1)

Latest price

EUR0.13

−0.05 (−27.57)
As at 01/01/2026
Market capitalisation
View equity

Mendus (IMMU)

Latest price

SEK5.60

0.10 (1.82)
As at 01/01/2026
Market capitalisation
SEK342m
View equity

MindMaze Therapeutics (MMTX)

Latest price

CHF1.90

−0.18 (−8.65)
As at 01/01/2026
Market capitalisation
CHF293m
View equity

Newron Pharmaceuticals (NWRN)

Latest price

CHF23.85

−0.60 (−2.45)
As at 01/01/2026
Market capitalisation
CHF426m
View equity

Nykode Therapeutics (NYKD)

Latest price

NOK2.41

0.08 (3.25)
As at 01/01/2026
Market capitalisation
NOK788m
View equity

Ocugen (OCGN)

Latest price

USD1.35

−0.02 (−1.46)
As at 01/01/2026
Market capitalisation
USD422m
View equity

Okyo Pharma (OKYO)

Latest price

USD2.07

0.13 (6.70)
As at 01/01/2026
Market capitalisation
USD78m
View equity

Oncopeptides (ONCO)

Latest price

SEK4.81

−0.16 (−3.22)
As at 01/01/2026
Market capitalisation
SEK1,243m
View equity

OpGen (OPGN)

Latest price

0.00 (0.00)
As at 01/01/2026
Market capitalisation
View equity
Laboratory Opgen

Update

Healthcare

OpGen — Cash concerns dampen active Q2

Laboratory Opgen

Flash note

Healthcare

OpGen — FIND collaboration advances to development

Flash note

Healthcare

OpGen — Feasibility milestone from FIND collaboration

Oryzon Genomics (ORY)

Latest price

EUR3.11

0.01 (0.32)
As at 01/01/2026
Market capitalisation
EUR249m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR5.15

−0.07 (−1.34)
As at 01/01/2026
Market capitalisation
EUR116m
View equity

Percheron Therapeutics (PER)

Latest price

AUD0.01

0.00 (12.50)
As at 01/01/2026
Market capitalisation
AUD9m
View equity